Maternal Mental Health Awareness Week: May 1-7, 2023
May 4, 2022 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.
Essential Reads: Transcranial Magnetic Stimulation for Perinatal Depression
TMS in pregnancy and the postpartum period appears to be a promising treatment option with no reports of adverse obstetric outcomes or congenital malformations.
Essential Reads: SSRI Antidepressants During Pregnancy and Risk of Hypertension, Preeclampsia
There is evidence that depression itself can increase risk for hypertension and preeclampsia. Future studies will help to clarify the complex interaction between depression, SSRI treatment and pre-eclampsia.
Updated Guidelines for Perinatal Mental Health Conditions: More Information and Support for Clinicians
Last month, the Alliance for Innovation on Maternal Health (AIM) launched a new Patient Safety Bundle addressing perinatal mental health conditions. The current revision addresses gaps in the safety bundle previously released in 2016. Patient [...]
National Eating Disorder Awareness Week: Focus on Pregnant and Postpartum Women
Eating disorders are common among women during the childbearing years; however, information on eating disorders in pregnant and postpartum women is relatively sparse.
Emergency Resources for Individuals with Perinatal Mental Health Issues
This very helpful list from Wendy Davis, PhD, Executive Director of Postpartum Support International, describes what the various emergency services can provide.
Risk of ADHD in Kids with Prenatal Exposure to Benzodiazepines or Z-Hypnotics
Prenatal exposure to benzodiazepines and Z-hypnotics was not associated with increased risk of ADHD in exposed children.
Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications
In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.
Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal)
This meta-analysis is reassuring regarding risk for malformations in children exposed prenatally to oxcarbazepine; however, we still need more data to fully assess reproductive safety.
Prenatal Exposure to Topiramate (Topamax): Impact on Neurodevelopmental Outcomes
Data from a Nordic register-based study observed a significant increase in risk for autism spectrum disorder and intellectual disability in children with prenatal exposure to topiramate.